ZnT8 and type 1 diabetes

Endocrine Journal

Volumn 59, Issue 7, 2012, Pages 531-537

  Kawasaki, Eiji ^a  

^a NAGASAKI UNIVERSITY HOSPITAL   (Japan)

Author keywords

Autoantibody; Autoantigen; Type 1 diabetes; Zinc transporter 8

Indexed keywords

AUTOANTIBODY; BIOLOGICAL MARKER; UNCLASSIFIED DRUG; ZINC TRANSPORTER; ZINC TRANSPORTER 8; ZINC TRANSPORTER 8 AUTOANTIBODY;

ANTIGEN SPECIFICITY; EARLY DIAGNOSIS; HUMAN; IMMUNE SYSTEM; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN SYNTHESIS; MOLECULAR DIAGNOSIS; NONHUMAN; PATHOGENESIS; PROTEIN FUNCTION; REVIEW;

ANIMALS; AUTOANTIBODIES; CARRIER PROTEINS; CATION TRANSPORT PROTEINS; DIABETES MELLITUS, TYPE 1; HUMANS; INSULIN; MODELS, BIOLOGICAL; ZINC;

EID: 84865613743     PISSN: 09188959     EISSN: 13484540     Source Type: Journal    
DOI: 10.1507/endocrj.EJ12-0069     Document Type: Review

References (31)

1. Garg VK, Gupta R, Goyal RK (1994) Hypozincemia in diabetes mellitus. J Assoc Physicians India 42:720-721.
2. Roussel AM, Kerkeni A, Zouari N, Mahjoub S, Matheau JM, Anderson RA (2003) Antioxidant effects of zinc supplementation in Tunisians with type 2 diabetes mellitus. J Am Coll Nutr 22:316-321.
3. Ho E, Quan N, Tsai YH, Lai W, Bray TM (2001) Dietary zinc supplementation inhibits NFκB activation and protects against chemically induced diabetes in CD1 mice. Exp Biol Med (Maywood) 226:103-111.
4. Kawasaki E, Gill RG, Eisenbarth GS (1999) Type 1 diabetes mellitus. In: Eisenbarth GS (ed) Molecular Mechanisms of Endocrine and Organ Specific Autoimmunity. R.G. Landes Company, Austin, Texas: 149-182.
5. Wenzlau JM, Juhl K, Yu L, Moua O, Sarkar SA, Gottlieb P, Rewers M, Eisenbarth GS, Jensen J, Davidson HW, Hutton JC (2007) The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes. Proc Natl Acad Sci U S A 104:17040-17045.
6. Emdin SO, Dodson GG, Cutfield JM, Cutfield SM (1980) Role of zinc in insulin biosynthesis. Some possible zinc-insulin interactions in the pancreatic B-cell. Diabetologia 19:174-182.
7. Hardy AB, Serino AS, Wijesekara N, Chimienti F, Wheeler MB (2011) Regulation of glucagon secretion by zinc: lessons from the β cell-specific Znt8 knockout mouse model. Diabetes Obes Metab 13 Suppl 1:112-117.
8. + channel mediates the zinc switch-off signal for glucagon response during glucose deprivation. Diabetes 59:128-134.
9. Lichten LA, Cousins RJ (2009) Mammalian zinc transporters: nutritional and physiologic regulation. Annu Rev Nutr 29:153-176.
10. Kelleher SL, McCormick NH, Velasquez V, Lopez V (2011) Zinc in specialized secretory tissues: roles in the pancreas, prostate, and mammary gland. Adv Nutr 2:101-111.
11. 2+ in pancreatic α-cells. J Biol Chem 283:10184-10197.
12. Lemaire K, Ravier MA, Schraenen A, Creemers JW, Van de Plas R, Granvik M, Van Lommel L, Waelkens E, Chimienti F, Rutter GA, Gilon P, in't Veld PA, Schuit FC (2009) Insulin crystallization depends on zinc transporter ZnT8 expression, but is not required for normal glucose homeostasis in mice. Proc Natl Acad Sci U S A 106:14872-14877.
13. Pound LD, Sarkar SA, Benninger RK, Wang Y, Suwanichkul A, Shadoan MK, Printz RL, Oeser JK, Lee CE, Piston DW, McGuinness OP, Hutton JC, Powell DR, O'Brien RM (2009) Deletion of the mouse Slc30a8 gene encoding zinc transporter-8 results in impaired insulin secretion. Biochem J 421: 371-376.
14. Wijesekara N, Dai FF, Hardy AB, Giglou PR, Bhattacharjee A, Koshkin V, Chimienti F, Gaisano HY, Rutter GA, Wheeler MB (2010) Beta cell-specific Znt8 deletion in mice causes marked defects in insulin processing, crystallisation and secretion. Diabetologia 53:1656-1668.
15. Nicolson TJ, Bellomo EA, Wijesekara N, Loder MK, Baldwin JM, Gyulkhandanyan AV, Koshkin V, Tarasov AI, Carzaniga R, Kronenberger K, Taneja TK, da Silva Xavier G, Libert S, Froguel P, Scharfmann R, Stetsyuk V, Ravassard P, Parker H, Gribble FM, Reimann F, Sladek R, Hughes SJ, Johnson PR, Masseboeuf M, Burcelin R, Baldwin SA, Liu M, Lara-Lemus R, Arvan P, Schuit FC, Wheeler MB, Chimienti F, Rutter GA (2009) Insulin storage and glucose homeostasis in mice null for the granule zinc transporter ZnT8 and studies of the type 2 diabetes-associated variants. Diabetes 58:2070-2083.
16. Eide DJ (2006) Zinc transporters and the cellular trafficking of zinc. Biochim Biophys Acta 1763:711-722.
17. Sladek R, Rocheleau G, Rung J, Dina C, Shen L, Serre D, Boutin P, Vincent D, Belisle A, Hadjadj S, Balkau B, Heude B, Charpentier G, Hudson TJ, Montpetit A, Pshezhetsky AV, Prentki M, Posner BI, Balding DJ, Meyre D, Polychronakos C, Froguel P (2007) A genomewide association study identifies novel risk loci for type 2 diabetes. Nature 445:881-885.
18. Cauchi S, Proenca C, Choquet H, Gaget S, De Graeve F, Marre M, Balkau B, Tichet J, Meyre D, Vaxillaire M, Froguel P (2008) Analysis of novel risk loci for type 2 diabetes in a general French population: the D.E.S.I.R. study. J Mol Med (Berl) 86:341-348.
19. Raj SM, Howson JM, Walker NM, Cooper JD, Smyth DJ, Field SF, Stevens HE, Todd JA (2009) No association of multiple type 2 diabetes loci with type 1 diabetes. Diabetologia 52:2109-2116.
20. Rink L, Haase H (2007) Zinc homeostasis and immunity. Trends Immunol 28:1-4.
21. Haase H, Ober-Blobaum JL, Engelhardt G, Hebel S, Heit A, Heine H, Rink L (2008) Zinc signals are essential for lipopolysaccharide-induced signal transduction in monocytes. J Immunol 181:6491-6502.
22. Prasad AS (2008) Zinc in human health: effect of zinc on immune cells. Mol Med 14:353-357.
23. Fraker PJ, Gershwin ME, Good RA, Prasad A (1986) Interrelationships between zinc and immune function. Fed Proc 45:1474-1479.
24. Prasad AS, Bao B, Beck FW, Kucuk O, Sarkar FH (2004) Antioxidant effect of zinc in humans. Free Radic Biol Med 37:1182-1190.
25. Chimienti F, Devergnas S, Pattou F, Schuit F, Garcia-Cuenca R, Vandewalle B, Kerr-Conte J, Van Lommel L, Grunwald D, Favier A, Seve M (2006) In vivo expression and functional characterization of the zinc transporter ZnT8 in glucose-induced insulin secretion. J Cell Sci 119:4199-4206.
26. Egefjord L, Jensen JL, Bang-Berthelsen CH, Petersen AB, Smidt K, Schmitz O, Karlsen AE, Pociot F, Chimienti F, Rungby J, Magnusson NE (2009) Zinc transporter gene expression is regulated by pro-inflammatory cytokines: a potential role for zinc transporters in beta-cell apoptosis? BMC Endocr Disord 9:7.
27. Kawasaki E, Matsuura N, Eguchi K (2006) Type 1 diabetes in Japan. Diabetologia 49:828-836.
28. Kawasaki E, Nakamura K, Kuriya G, Satoh T, Kobayashi M, Kuwahara H, Abiru N, Yamasaki H, Matsuura N, Miura J, Uchigata Y, Eguchi K (2011) Differences in the humoral autoreactivity to zinc transporter 8 between childhood-and adult-onset type 1 diabetes in Japanese patients. Clin Immunol 138:146-153.
29. Wenzlau JM, Liu Y, Yu L, Moua O, Fowler KT, Rangasamy S, Walters J, Eisenbarth GS, Davidson HW, Hutton JC (2008) A common non-synonymous single nucleotide polymorphism in the SLC30A8 gene determines ZnT8 autoantibody specificity in type 1 diabetes. Diabetes 57:2693-2697.
30. Kawasaki E, Uga M, Nakamura K, Kuriya G, Satoh T, Fujishima K, Ozaki M, Abiru N, Yamasaki H, Wenzlau JM, Davidson HW, Hutton JC, Eguchi K (2008) Association between anti-ZnT8 autoantibody specificities and SLC30A8 Arg325Trp variant in Japanese patients with type 1 diabetes. Diabetologia 51:2299-2302.
31. Dang M, Rockell J, Wagner R, Wenzlau JM, Yu L, Hutton JC, Gottlieb PA, Davidson HW (2011) Human type 1 diabetes is associated with T cell autoimmunity to zinc transporter 8. J Immunol 186:6056-6063.